Novocure INC
At a glance
EmployeesNot reported
In business since2000
HeadquartersPortsmouth, NH
SAM.gov UEIP3S3GK3DTUA8
Novocure is a global oncology company that develops Tumor Treating Fields (TTFields) therapy for cancer treatment. The company manufactures products named Optune Gio, Optune Lua, and Optune Pax, with Optune Pax approved by the U.S. FDA for locally advanced pancreatic cancer when used with gemcitabine and nab-paclitaxel.
Summarized from the company’s own website
What they make
Electrical Tumor Treatment FieldsElectrical Tumor Treatment Fields For Non-Small Cell Lung CancerLow Electric Field Generator For Pancreatic Cancer TreatmentStimulator, Low Electric Field, Tumor Treatment
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Novocure INC | Portsmouth | NH | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.